Skip to menu Skip to content Skip to footer

2009

Conference Publication

Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical Prostatectomy

Samaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2009). Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical Prostatectomy. 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Boston, MA, United States, Mar 07-13, 2009. NEW YORK: NATURE PUBLISHING GROUP.

Correlation of Conventional and Modified Gleason Grading of Prostatic Adenocarcinoma after Radical Prostatectomy

2008

Journal Article

Ductal adenocarcinoma of the prostate - Current opinion and controversies

Samaratunga, Hemamali and Delahunt, Brett (2008). Ductal adenocarcinoma of the prostate - Current opinion and controversies. Analytical and Quantitative Cytology and Histology, 30 (4), 237-246.

Ductal adenocarcinoma of the prostate - Current opinion and controversies

2008

Journal Article

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation

Willems, Amber J., Dawson, Sarah -J., Samaratunga, Hema, De Luca, Alessandro, Antill, Yoland C., Hopper, John L. and Thorne, Heather J. (2008). Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clinical Cancer Research, 14 (10), 2953-2961. doi: 10.1158/1078-0432.CCR-07-5237

Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation

2008

Journal Article

Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progression

Ramsay, Andrew J., Dong, Ying, Hunt, Melanie L., Linn, MayLa, Samaratunga, Hemamali, Clements, Judith A. and Hooper, John D. (2008). Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progression. The Journal of Biological Chemistry, 283 (18), 12293-12304. doi: 10.1074/jbc.M709493200

Kallikrein-related peptidase 4( KLK4)initiates intracellular signaling via protease-activated receptors(PARs):KLK4 and PAR-2 are co-expressed during prostate cancer progression

2008

Conference Publication

Hybrid tumors in renal oncocytosis: the missing link between oncocytoma and chromophobe renal cell carcinoma?

Cheng, Liang, Gobbo, Stefano, Eccher, Albino, Eble, John, Delahunt, Brett, Grignon, David, Samaratunga, Hemamali, Martignoni, Guido, Zhang, Shaobo, Wang, Mingsheng, Cossu-Rocca, Paolo and Brunelli, Matteo (2008). Hybrid tumors in renal oncocytosis: the missing link between oncocytoma and chromophobe renal cell carcinoma?. NEW YORK: SPRINGER.

Hybrid tumors in renal oncocytosis: the missing link between oncocytoma and chromophobe renal cell carcinoma?

2008

Journal Article

A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus

Myers, Stephen A., Kaushal, Aneel, Dong, Ying, Lai, John, Tan, Olivia L., Bui, Loan T., Hunt, Melanie L., Digby, Matthew R., Samaratunga, Hemamali, Gardiner, Robert A., Clements, Judith A. and Hooper, John D. (2008). A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Prostate, 68 (4), 381-399. doi: 10.1002/pros.20685

A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus

2008

Journal Article

Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function

Dong, Ying, Matigian, Nick, Harvey, Tracey J., Samaratunga, Hemamali, Hooper, John D. and Clements, Judith A. (2008). Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function. Biological Chemistry, 389 (2), 99-109. doi: 10.1515/BC.2008.013

Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function

2008

Journal Article

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

Kelly Anne Landers, Samaratunga, Hemamali, Linda Teng, Buck, M., Burger, Michelle J., Betty Scells, Lavin, Martin F. and Gardiner, Robert A. (2008). Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. British Journal of Cancer, 99 (3), 491-501. doi: 10.1038/sj.bjc.6604486

Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

2008

Conference Publication

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)

Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A. and Hooper, John D. (2008). Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). 2nd International Symposium on Kallikrein and Kallikrein-Related Peptidases (ISK 2007), Santorini, Greece, 16-18 October 2007. Berlin, Germany: Walter de Gruyter. doi: 10.1515/BC.2008.078

Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs)

2008

Journal Article

Cellular angiofibroma of the scrotum

Samaratunga, Hemamali and Fitzpatrick, Peter (2008). Cellular angiofibroma of the scrotum. Pathology, 40 (3), 330-333. doi: 10.1080/00313020701716409

Cellular angiofibroma of the scrotum

2008

Conference Publication

Any proportion of ductal adenocarcinoma of the prostate predicts higher stage disease

Samaratunga, H., Delahunt, B., Duffy, D., Brown, I. and Yaxley, J. (2008). Any proportion of ductal adenocarcinoma of the prostate predicts higher stage disease. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver, CO, United States, 1-7 March 2008. Amsterdam, Netherlands: Elsevier.

Any proportion of ductal adenocarcinoma of the prostate predicts higher stage disease

2008

Conference Publication

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

Samaratunga, H., Delahun, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver CO, United States, Mar 01-07, 2008. London, United Kingdom: Nature Publishing Group.

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

2008

Journal Article

What is the molecular pathology of low-risk prostate cancer?

Samaratunga, Hemamali and Epstein, Jonathan I. (2008). What is the molecular pathology of low-risk prostate cancer?. World Journal of Urology, 26 (5), 431-436. doi: 10.1007/s00345-008-0260-5

What is the molecular pathology of low-risk prostate cancer?

2008

Conference Publication

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

Samaratunga, H., Delahunt, B., Duffy, D. and Yaxley, J. (2008). Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population. 97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Denver Co, Mar 01-07, 2008. NEW YORK: NATURE PUBLISHING GROUP.

Anterior dominant prostate cancer compared with posterior cancers in a PSA non-screened population

2007

Journal Article

Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp

Samaratunga, Hemamali and Letizia, Bernadette (2007). Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp. Pathology, 39 (5), 476-481. doi: 10.1080/00313020701570004

Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp

2007

Journal Article

Significance of minute focus of adenocarcinoma on prostate needle biopsy

Samaratunga, Hemamali, Yaxley, John, Kerr, Kris, McClymont, Kelly and Duffy, David (2007). Significance of minute focus of adenocarcinoma on prostate needle biopsy. Urology, 70 (2), 299-302. doi: 10.1016/j.urology.2007.03.068

Significance of minute focus of adenocarcinoma on prostate needle biopsy

2007

Journal Article

A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006)

De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farre, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2007). A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 31 (4), 652-652.

A working group classification of focal prostate atrophy lesions. (vol 30, pg 1281, 2006)

2007

Conference Publication

Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid

Gardiner, R. A., Burger, M. J., Landers, K. A., Roper, K., Scells, B., Samaratunga, M. L. T. H., Yaxley, J., Stening, S. and Lavin, M. F. (2007). Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid. Urological Society of Australia and New Zealand 60th Annual Scientific Meeting, Adelaide, Australia, 18-22 February 2007. London, UK: Blackwell Science. doi: 10.1111/j.1464-410X.2007.06719.x

Multiple molecular markers in the diagnosis of prostate cancer from prostatic fluid

2006

Journal Article

A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006)

De Marzo, A. M., Platz, E. A., Epstein, J., Ali, T., Billis, A., Chan, T. Y., Cheng, L., Datta, M., Egevad, L., Ertoy-Baydar, D., Farree, X., Fine, S. W., Iczkowski, K. A., Ittmann, M., Knudsen, B. S., Loda, M., Lopez-Beltran, A., Magi-Galluzzi, C., Mikuz, G., Montironi, R., Pikarsky, E., Pizov, G., Rubin, M. A., Samaratunga, H., Sebo, T., Sesterhenn, I. A., Shah, R. B., Signoretti, S., Simko, J. ... Lucia, M. S. (2006). A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006). American Journal of Surgical Pathology, 30 (11), 1489-1489.

A working group classification of focal prostate atrophy lesions (vol 30, pg 1281, 2006)

2006

Conference Publication

The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy

Samaratunga, H, Yaxley, J, Kerr, K and McClymont, K (2006). The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy. 95th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Atlanta, Georgia, 11-17 February 2006 . London, United Kingdom: Nature Publishing Group.

The significance of finding a small focus of prostatic adenocarcinoma on needle biopsy